{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T21:41:50Z","timestamp":1782164510500,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.carrev.2019.10.017","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T19:57:52Z","timestamp":1571860672000},"page":"745-753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Polymer-Free vs. Polymer-Coated Drug-Eluting Stents for the Treatment of Coronary Artery Disease: A Meta-Analysis of 16 Randomized Trials"],"prefix":"10.1016","volume":"21","author":[{"given":"Monica","family":"Verdoia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvin","family":"Kedhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Suryapranata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Galasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2019.10.017_bb0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijcard.2017.06.022","article-title":"Drug-eluting stent in primary angioplasty (DESERT 3) cooperation. Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: a pooled patient-level meta-analysis of randomized trials","volume":"244","author":"De Luca","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2019.10.017_bb0010","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jcin.2014.02.016","article-title":"Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial","volume":"7","author":"Di Lorenzo","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.10.017_bb0015","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/archinternmed.2012.758","article-title":"Drug-eluting stent in primary angioplasty (DESERT) cooperation. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials","volume":"172","author":"De Luca","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.carrev.2019.10.017_bb0020","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00392-018-1252-0","article-title":"Stent thrombosis rates the first year and beyond with new- and old-generation drug-eluting stents compared to bare metal stents","volume":"107","author":"Varenhorst","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.carrev.2019.10.017_bb0025","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.jacc.2015.04.017","article-title":"Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"65","author":"Palmerini","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.10.017_bb0030","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/0003319718768656","article-title":"Percutaneous versus surgical revascularization for left main or multivessel coronary artery disease: results from a large-scale meta-analysis in the era of drug-eluting stents","volume":"69","author":"Verdoia","year":"2018","journal-title":"Angiology"},{"issue":"4","key":"10.1016\/j.carrev.2019.10.017_bb0035","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1586\/erc.11.5","article-title":"Current and future drug-eluting coronary stent technology","volume":"9","author":"Ielasi","year":"2011","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.carrev.2019.10.017_bb0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.10.017_bb0045","first-page":"34","article-title":"Vascular response to bioresorbable polymer sirolimus-eluting stent vs. permanent polymer everolimus-eluting stent at 9-month follow-up: an optical coherence tomography sub-study from the CENTURY II trial","volume":"17","author":"Kuramitsu","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2019.10.017_bb0050","doi-asserted-by":"crossref","first-page":"557","DOI":"10.5603\/CJ.a2014.0002","article-title":"Impact of drug-eluting stents with different coating strategies on stent thrombosis: a meta-analysis of 19 randomized trials","volume":"21","author":"Niu","year":"2014","journal-title":"Cardiol J"},{"key":"10.1016\/j.carrev.2019.10.017_bb0055","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrcardio.2013.13","article-title":"New concepts in the design of drug eluting coronary stents","volume":"10","author":"Garg","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.carrev.2019.10.017_bb0060","first-page":"435e42","article-title":"Polymer-free sirolimus-eluting versus polymer-based paclitaxel-eluting stents: an individual patient data analysis of randomized trials","volume":"66","author":"Cassese","year":"2013","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.carrev.2019.10.017_bb0065","first-page":"221","article-title":"Polymer-free versus permanent polymer drug eluting stents in coronary artery disease: a meta-analysis of 10 RCTs with 6575 patients","volume":"1","author":"Wu","year":"2015","journal-title":"Chronic Dis Transl Med"},{"key":"10.1016\/j.carrev.2019.10.017_bb0070","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.002943","article-title":"Stent polymers: do they make a difference?","volume":"9","author":"Rizas","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.10.017_bb0075","first-page":"339","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"b2700","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.carrev.2019.10.017_bb0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jcin.2015.09.008","article-title":"Polymer-free biolimus A9-coated stents in the treatment of de novo coronary lesions 4- and 12-month angiographic follow-up and final 5-year clinical outcomes of the prospective, multicenter BioFreedom FIM clinical trial","volume":"9","author":"Costa","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.10.017_bb0085","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jacc.2011.12.009","article-title":"A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions","volume":"59","author":"Carrie","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.10.017_bb0090","first-page":"3393","article-title":"Six-month angiographic and one year clinical outcomes of polymer free paclitaxel-eluting stent in patients with ST-segment elevation myocardial infarction: a comparison with permanent polymer sirolimus-eluting stent","volume":"125","author":"Dang","year":"2012","journal-title":"Chin Med J"},{"key":"10.1016\/j.carrev.2019.10.017_bb0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1755-5922.2012.00319.x","article-title":"Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial","volume":"31","author":"Chen","year":"2013","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.carrev.2019.10.017_bb0100","first-page":"E23e8","volume":"81","author":"King","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.10.017_bb0105","first-page":"923e31","article-title":"A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs polymer-based drug-eluting stents","volume":"30","author":"Byrne","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2019.10.017_bb0110","doi-asserted-by":"crossref","first-page":"1489e94","DOI":"10.1136\/hrt.2009.172379","article-title":"Randomised trial of three rapamycin eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results","volume":"95","author":"Byrne","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.carrev.2019.10.017_bb0115","doi-asserted-by":"crossref","first-page":"624e32","DOI":"10.1161\/CIRCULATIONAHA.111.026732","volume":"124","author":"Massberg","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2019.10.017_bb0120","doi-asserted-by":"crossref","first-page":"E1650","DOI":"10.1016\/S0735-1097(13)61650-2","article-title":"Five-year clinical follow-up of a randomized comparison between a polymer-free sirolimus eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus","volume":"61","author":"Stiermaier","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.10.017_bb0125","doi-asserted-by":"crossref","unstructured":"Rozemeijer R, Stein M, Voskuil M et al. Randomized all-comers evaluation of a permanent polymer zotarolimus-eluting stent versus a polymer-free amphilimus-eluting stent: (ReCre8) a multicenter, non-inferiority trial. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.037707","DOI":"10.1161\/CIRCULATIONAHA.118.037707"},{"key":"10.1016\/j.carrev.2019.10.017_bb0130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcin.2015.09.020","article-title":"A randomized comparison of reservoir-based polymer-free amphilimus-eluting stents versus everolimus-eluting stents with durable polymer in patients with diabetes mellitus: the RESERVOIR clinical trial","volume":"9","author":"Romaguera","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.10.017_bb0135","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCINTERVENTIONS.113.000800","article-title":"Randomized comparison between polymer-free versus polymer-based paclitaxel-eluting stent two-year final clinical results","volume":"7","author":"Shiratori","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.10.017_bb0140","series-title":"A Randomized Trial Comparing a Polymer-free Coronary Drug-eluting Stent With an Ultra-thin Strut Bioresorbable Polymer-based Drug-eluting Stent in an All-comers Patient Population","author":"Jensen","year":"2018"},{"issue":"3","key":"10.1016\/j.carrev.2019.10.017_bb0145","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.ijcard.2013.03.034","article-title":"Two-year clinical outcomes of different drug-eluting stents with different polymer coating strategies in coronary artery heart disease: a multi-centre, randomised, controlled clinical trial","volume":"168","author":"Zhang","year":"2013","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2019.10.017_bb0150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jacc.2013.04.045","article-title":"Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial","volume":"62","author":"Natsuaki","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.carrev.2019.10.017_bb0155","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3760\/cma.j.issn.0366-6999.20133148","article-title":"Nine-month angiographic and two-year clinical follow-up of polymer-free sirolimus-eluting stent versus durable-polymer sirolimus-eluting stent for coronary artery disease: the Nano randomized trial","volume":"127","author":"Zhang","year":"2014","journal-title":"Chin Med J"},{"key":"10.1016\/j.carrev.2019.10.017_bb0160","doi-asserted-by":"crossref","first-page":"1940e8","DOI":"10.1016\/S0140-6736(11)61672-3","article-title":"Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial","volume":"378","author":"Stefanini","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2019.10.017_bb0165","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free drug coated coronary stents in patients at high bleeding risk","volume":"373","author":"Urban","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2019.10.017_bb0170","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/0003319715586500","article-title":"Optimal duration of dual antiplatelet therapy after DES implantation: a meta-analysis of 11 randomized trials","volume":"67","author":"Verdoia","year":"2016","journal-title":"Angiology"},{"key":"10.1016\/j.carrev.2019.10.017_bb0175","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/FJC.0000000000000052","article-title":"Benefits from new ADP antagonists as compared with clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta-analysis of randomized trials","volume":"63","author":"Verdoia","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.carrev.2019.10.017_bb0180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ahj.2016.04.016","article-title":"Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial","volume":"178","author":"Camaro","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2019.10.017_bb0185","doi-asserted-by":"crossref","DOI":"10.4244\/EIJ-D-19-00539","article-title":"Final results of the Randomised Evaluation of short-term DUal antiplatelet therapy in patients with acute Coronary syndromE treated with a new generation stent (REDUCE) trial","author":"De Luca","year":"2019","journal-title":"EuroIntervention"},{"issue":"4","key":"10.1016\/j.carrev.2019.10.017_bb0190","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.numecd.2013.11.002","article-title":"Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease","volume":"24","author":"Verdoia","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.carrev.2019.10.017_bb0195","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11239-014-1052-y","article-title":"Sirolimus-eluting versus paclitaxel-eluting stent in primary angioplasty: a pooled patient-level meta-analysis of randomized trials","volume":"38","author":"De Luca","year":"2014","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.carrev.2019.10.017_bb0200","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jacc.2010.07.028","article-title":"In-stent restenosis in the drug-eluting stent era","volume":"56","author":"Dangas","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.10.017_bb0205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40204-018-0097-y","article-title":"Cardiovascular stents: overview, evolution, and next generation","volume":"7","author":"Borhani","year":"2018","journal-title":"Prog Biomater"},{"key":"10.1016\/j.carrev.2019.10.017_bb0210","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1160\/TH13-02-0092","article-title":"DESERT cooperation. Time course, predictors and clinical implications of stent thrombosis following primary angioplasty. Insights from the DESERT cooperation","volume":"110","author":"De Luca","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.carrev.2019.10.017_bb0215","doi-asserted-by":"crossref","first-page":"384e93","DOI":"10.1161\/CIRCINTERVENTIONS.109.891192","article-title":"New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems","volume":"3","author":"Abizaid","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.10.017_bb0220","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/CIRCULATIONAHA.104.508937","article-title":"Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents","volume":"112","author":"Finn","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2019.10.017_bb0225","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jacc.2007.01.015","article-title":"Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years","volume":"49","author":"Ellis","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.10.017_bb0230","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.atherosclerosis.2013.12.024","article-title":"Short and long-term safety and efficacy of polymer-free vs. durable polymer drug-eluting stents. A comprehensive meta-analysis of randomized trials including 6178 patients","volume":"233","author":"Navarese","year":"2014","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.carrev.2019.10.017_bb0235","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12872-017-0603-5","article-title":"Efficacy and safety of polymer-free stent versus polymer-permanent drug-eluting stent in patients with acute coronary syndrome: a meta-analysis of randomized control trials","volume":"17","author":"Gao","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.carrev.2019.10.017_bb0240","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/joic.12522","article-title":"Polymer-free versus permanent polymer-coated drug eluting stents for the treatment of coronary artery disease: a meta-analysis of randomized trials","volume":"31","author":"Nogic","year":"2018","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.carrev.2019.10.017_bb0245","author":"Krukoff"},{"key":"10.1016\/j.carrev.2019.10.017_bb0250","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/jbm.a.34806","article-title":"Coronary drug-eluting stents: from design optimization to newer strategies","volume":"102","author":"Sun","year":"2014","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.carrev.2019.10.017_bb0255","doi-asserted-by":"crossref","first-page":"813e31","DOI":"10.1517\/17425247.2011.572068","article-title":"Stents as a platform for drug delivery","volume":"8","author":"Lei","year":"2011","journal-title":"Expert Opin Drug Deliv"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919306700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919306700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:16:50Z","timestamp":1761560210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838919306700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1553838919306700"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2019.10.017","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymer-Free vs. Polymer-Coated Drug-Eluting Stents for the Treatment of Coronary Artery Disease: A Meta-Analysis of 16 Randomized Trials","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2019.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}